Muhammad Bilal Abid

29PUBLICATIONS
139CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 02, 2026
Real-world outcomes with BCMA- and GPRC5D-targeting bispecific antibodies in plasma cell leukemia.

|May 11, 2026
Bispecific Antibodies in Hematologic Malignancies in the Outpatient and Community Settings.

|Jul 22, 2025
Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOS.

Nasheed M Hossain, Kwang Woo Ahn, Jinalben Patel

|May 29, 2025
Efficacy of Total-Body Irradiation-based Intensified Myeloablative Regimens for Acute Leukemia-An International Collaborative Study.

Yasuyuki Arai, Ruta Brazauskas, Naya He

|May 28, 2025
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR.

Kitsada Wudhikarn, Megan M Herr, Min Chen

|Mar 30, 2025
Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response.

Oren Pasvolsky, Muhammad Bilal Abid, Denái R Milton

Pageof 5

Frequent Collaborators

5 joint publications

Akshay Sharma

3 joint publications

Sachiko Seo

3 joint publications

Michael R Grunwald

3 joint publications

Mohamed A Kharfan-Dabaja